Research & Development



  草長鶯飛的日子里,也是上林苑景致最好的時侯,一座茅草亭,兩杯淡酒,幾樣素菜,讓離別意顯得愈發的濃烈。   隨著一場大戰僵持的時間越來越長,武器越來越先進,戰爭拼的已經是國力,已經是集體的力量了,沒有雄厚國力支撐,即便是蓋世名將,也沒有辦法迅速的打贏一場仗。亚洲   而且就在距離他們身後不到四十里的地方,如果騎兵全速狂奔的話,半個時辰就會追到。图片偷拍网   有了富貴鎮這個舞台,東方朔胸中的郁悶之氣一掃而空,他確信,這座城池一定會在他的手中拔地而起的。   歇古歇斯底里的吼叫道,他被雲瑯描繪的場面嚇壞了,不是因為雲瑯說的話惡毒,而是因為雲瑯說的每一個字可能都會成為現實!超碰在线免费公开视频   霍去病探手朝城下看看,只見羌人的尸體在城下堆積如山,並且從城下一直延伸到百丈以外,遂搖搖頭道︰“沒希望了,還是殺掉來的干淨些。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo